The Mdm2 gene is the best known cellular regulator of p53 tumor suppressor activity. We report here the cloning and characterization of Xdm2, its homolog in Xenopus laevis. Human, mouse and Xenopus MDM2 proteins are more than 65% identical in several regions which are likely to be important for the biological activities of MDM2. Region I is sucient for binding p53 and inhibiting its G 1 arrest and apoptosis functions. Region II contains most of a central acidic region required for interaction with the L5 ribosomal protein and a putative C4 zinc ®nger. Region III is nearly identical from Xenopus to human and comprises the RING ®nger domain. We show that this structural conservation is associated with the conservation of three biochemical activities of MDM2; binding to the p53 and L5 proteins and speci®cally to RNA. Lastly, Xdm2 expression during early development is mainly restricted from the oocyte stage I/II to the blastula stage and is possibly independent of transcriptional activation by p53. These data as well as the utilization of Xenopus laevis to investigate the roles of MDM2 and p53 during early embryogenesis are discussed.
Introduction
The Mdm2 oncogene was initially identi®ed by virtue of its ampli®cation in a spontaneously transformed Balb/c 3T3 derived cell line (Cahilly-Snyder et al., 1987) . Subsequently, a direct role for Mdm2 in tumorigenesis was provided by its ability to enhance the tumorigenic potential of NIH3T3 cells and Rat2 cells when overexpressed (Fakharzadeh et al., 1991) . In addition, overexpression of Mdm2 was shown to immortalize primary rat embryo ®broblasts and to transform these cells in conjuction with an activated ras oncogene (Finlay, 1993) . More recent studies have shown that Mdm2 gene ampli®cation and subsequent overexpression occur frequently in many human tumors including soft tissue sarcomas, osteosarcomas and gliomas (Cordon-Cardo et al., 1994; Ladanyi et al., 1993; Leach et al., 1993; Oliner et al., 1992; Reifenberger et al., 1993) . Alternatively, MDM2 protein accumulation may result from mechanisms other than gene ampli®cation such as enhanced translation or gene translocation Berberich and Cole, 1994) .
The oncogenic activity of Mdm2 is due, at least in part, to its ability to bind and inhibit the transcriptional activation activity of the p53 tumor suppressor protein (Momand et al., 1992) . This inhibition occurs through the N-terminal domain of MDM2 (residues 19 ± 102), which forms a complex with the N-terminal transactivation domain of p53 Chen et al., 1993; Brown et al., 1993; Leng et al., 1995) . Furthermore, MDM2 has recently been shown to inhibit G 1 arrest and apoptotic functions of p53 (Chen et al., 1996; Haupt et al., 1996) . The Mdm2 gene is transcriptionally activated by p53, thus forming an autoregulatory negative feedback loop (Barak et al., 1993; Wu et al., 1993) . By activating its own negative regulator, p53 presumably signals the cell to resume proliferation after a p53-mediated G 1 arrest in response to DNA damage Perry et al., 1993) . Importantly, this negative regulation of p53 by MDM2 is essential for viability during an early step in mouse embryogenesis as indicated by Mdm2 gene knock-out experiments (Jones et al., 1995; Montes de Oca Luna et al., 1995) . Mice lacking Mdm2 exhibit embryonic lethality, but this phenotype is rescued in a p53 null background. Therefore, the embryonic lethality is due to the presence of p53 protein devoid of regulation by MDM2.
In addition to p53 regulation, recent studies have demonstrated that MDM2 can interact with the retinoblastoma protein, pRB, and the E2F1/DP1 transcription factor (Xiao et al., 1995; Martin et al., 1995) . It has been speculated that these interactions synergistically stimulate the transcriptional activity of E2F1/DP1 by relieving the negative control of pRB on E2F1 and directly activating E2F1, thereby promoting the G 1 to S phase transition in cells. Activation of the transcriptional activity of E2F1/DP1 was mediated by the N-terminus of MDM2 protein, the same domain responsible for p53 regulation.
Despite its role as a regulator of p53 and E2F1/DP1, several lines of evidence have suggested that MDM2 may exhibit other as yet unidenti®ed functions. First, Mdm2 mRNAs are subjected to multiple splicing events giving rise to several forms of the protein, some of them missing the N-terminus Haines et al., 1994; Barak et al., 1994) . Second, we have demonstrated that MDM2 associates in vitro and in vivo with the ribosomal L5 protein/5S rRNA complex through its central acidic domain (Marechal et al., 1994; Elenbaas et al., 1996) . This observation raised the intriguing possibility of a role for MDM2 in translational regulation. Third, the C-terminus of MDM2 contains two domains of unknown function: a C4 zinc ®nger domain and a RING ®nger domain (Boddy et al., 1994) . The RING ®nger domain coordinates two molecules of zinc and folds as a single domain, but its function is unknown (Freemont, 1993; Borden et al., 1995) . Recently, MDM2 has been shown to interact with the homopolyribonucleotide poly(G) and to speci®cally associate with RNA in vitro, this last interaction being mediated through the RING ®nger domain .
Since p53 is structurally and functionally conserved from Xenopus to human (Soussi et al., 1987; Cox et al., 1994; Ridgway et al., 1994; Wang et al., 1995) we asked whether Mdm2, its main negative regulator, was present in Xenopus laevis and whether known functions of MDM2 have been preserved during evolution. We report here the cloning and characterization of the Xenopus homolog of Mdm2 (Xdm2). Based on local homologies between the human, mouse and Xenopus MDM2 proteins, three conserved regions were de®ned. We show that evolutionary conservation of these regions is related to the conservation of several biochemical activities previously identi®ed for human and mouse forms of MDM2. Speci®cally, XDM2 was able to associate with the human, mouse and Xenopus p53 proteins, with the mouse ribosomal protein L5 and with a pool of RNA sequences known to interact speci®cally with the RING ®nger of MDM2. Finally, we show that Xdm2 is expressed from the oocyte stage I/II to the blastula stage in Xenopus laevis and that this expression may be independent of p53-mediated transcriptional activation.
Isolation of Xenopus Mdm2 cDNA homolog
A 1473 bp probe derived from the human Mdm2 (Hdm2) cDNA was used to screen 500 000 clones from a lgt10 Xenopus cDNA library generated from oocytes of a single individual (Rebagliati et al., 1985; . Nine clones were initially isolated which hybridized to the probe. Based on a partial sequencing of the 5' and 3' ends, comparative restriction maps, and Southern blotting with four non-overlapping probes covering the entire Hdm2 cDNA, ®ve clones had only minor, local homologies with the Hdm2 sequence and were not subjected to further anlaysis. Four cDNA clones, named Xdm2 24.1 (1586 bp), 24.2 (1494 bp), 31.2 (711 bp) and 23.1 (1616 bp), were subcloned in a Bluescript vector and sequenced. The full-length Xdm2 24.1 cDNA contained an open reading frame of 473 amino acids encoding a putative 53.4 kDa protein ( Figure 1A ). Xdm2 24.2 and 31.2 diered from the Xdm2 24.1 clone by two point mutations (C to A on position 1043; A to G on position 1246) and shorter 5' ends. Direct sequencing of the 24.1 original phage revealed that these two point mutations did not result from a subcloning artifact. Xdm2 24.2 and 31.2 were most likely deleted forms rather than alternative spliced products of a longer transcript. Surprisingly, another partial Xdm2 cDNA (Xdm2 23.1) exhibited numerous dierences compared to Xdm2 24.1 in the coding and non-coding regions ( Figure 1A ). This strongly argues for the presence and expression of at least two dierent Mdm2 alleles in Xenopus laevis, which is in agreement with the pseudotetraploidy of the genome (Bisbee et al., 1977; Kobel and Pasquier, 1986) .
The Xdm2 24.1, human and mouse Mdm2 cDNAS are 55.2% homologous at the nucleotide level within the open reading frame. Alignment of the XDM2 24.1 amino acid sequence with that of the human (HDM2) and mouse MDM2 proteins reveals that these three proteins are 54% identical ( Figure 1B ). Three highly conserved regions could be de®ned; they are 68 amino acids long or more, limited by conserved residues and at least 65% identical from Xenopus to human MDM2. Conversely, the¯anking regions are less than 45% identical although some local homologies are still detected. Region I encompasses Ileu 19 to Val 108, a region containing the previously de®ned binding sites for p53 and E2F1/DP1 Oliner et al., 1993; Martin et al., 1995) . Region II covers a region spanning from Ser 242 to Pro 331. It contains most part of a central acidic domain (Asp 243 to Asp 301) required for the interaction with the ribosomal L5 protein and is followed by a C4 zinc ®nger motif (Cys305 to Cys322) . The MDM2 C4 zinc ®nger is signi®cantly homologous to several RNA binding proteins zinc ®ngers such as in CAZ, TLS and EWS (Immanuel et al., 1995; Crozat et al., 1993; Delattre et al., 1992) (Figure 1C ). MDM2 C4 zinc ®nger contribution to RNA binding is still to be evaluated. Region III (Lys 422 to Phe 490) is nearly identical from human to Xenopus and has been classi®ed as a RING ®nger domain (Boddy et al., 1994) . It should be noted that although the Xdm2 23.1 sequence has several dierences at the nucleotide and at the amino acid sequence level, none of these mutations alters the amino acid sequence within the conserved regions. Although no speci®c biological function has been attributed to the central acidic domain or the C-terminal zinc and RING ®nger domains of the protein, conservation of these regions during evolution strongly suggests that they possess important activities for MDM2. Lastly, several additional putative functional motifs are conserved including a basic nuclear localization signal (Arg 181 to Lys 185) and several DNA-PK phosphorylation sites at Ser 388, Ser 395 and Ser 407 (Anderson and LeesMiller, 1992) .
The biochemical activities of binding to the p53 and L5 ribosomal proteins and speci®cally to RNA are conserved in the Xenopus MDM2 protein
Since the conserved regions of XDM2 map to regions of the protein with previously identi®ed biochemical activities of human and mouse MDM2, we tested whether XDM2 could eciently interact with Xenopus p53 as well as with the murine L5 ribosomal protein and RNA. In order to investigate these biochemical activities of XDM2, baculovirus expression vectors for XDM2 and a hemagglutinin (HA) epitope-tagged XDM2 were generated with the 24.1 cDNA clone. As an initial experiment, a panel of monoclonal antibodies generated against HDM2 was screened to ®nd antibodies that react with XDM2. Out of 11 HDM2 monoclonal antibodies screened, only the 3G5 antibody recognized XDM2 and was used in subsequent experiments (data not shown). XDM2 had an apparent molecular weight of 80 kDa despite a predicted molecular weight of 53.4 kDa. This result is in agreement with observations made on MDM2 and HDM2 and is likely due to the presence of a central acidic domain . The fact that 3G5 recognizes XDM2 is interesting because 3G5 recognizes HDM2 that is not in complex with p53 and therefore likely recognizes the p53-binding surface of HDM2 . The 3G5 antibody likely recognizes a conformational epitope between residues 59 and 89 of HDM2, and point mutations have been identi®ed in this highly conserved region which abolish the interaction with p53 (Freedman et al., 1996, in preparation). Thus, these observations suggest that the structure of the p53-binding surface on HDM2 is conserved in XDM2. In addition, comparison of p53 amino acid sequences from dierent species has indicated that the MDM2 binding site on p53 is highly conserved (Lin et al., 1994) .
In order to test whether the p53/MDM2 interaction is conserved in Xenopus, Sf9 insect cells were infected with baculovirus expression vectors for HA-tagged XDM2, for Xenopus p53 (Xp53) or for both proteins followed by labeling with [ (MDM2) and Xenopus (XDM2). Proteins were aligned and compared using the Clustal algorithm (Higgins and Sharp, 1988) . Numbers refer to amino acid residues of HDM2. Conserved Regions I, II and III are shadowed. A putative nuclear localization site is boxed. Three putative conserved DNA-PK sites have been underlined. In Regions II and III, cysteine and histidine residues predicted to be involved in zinc coordination have been boxed. Within the RING ®nger in Region III, the Cys3 residue has been substituted for a Thr which has been speculated to be involved in zinc coordination, thus forming a variant of the RING ®nger domain (Boddy et al., 1994) . (C) Comparison of MDM2 homologs, CAZ, EWS and TLS C4 zinc ®ngers. A search for homologies was performed on the GenBank database using the Fasta algorithm (Pearson and Lipman, 1988) . Optimal alignments between the dierent C4 zinc ®ngers were performed according to the Best®t procedure (Smith and Waterman, 1981) . First and last amino acid positions are indicated for each protein. Common amino acids between MDM2 homologs and CAZ, EWS or TLS are shadowed. XDM2 C4 zinc ®nger region is 42% identical to CAZ, 31% identical to EWS and 35% identical to TLS
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Cloning and characterization of Mdm2 homolog in Xenopus laevis V Marechal et al XDM2 or Xp53 as previously described . Complex formation between HA XDM2 or Xp53 was easily observed when insect cells were coinfected with HA XDM2 and Xp53 baculoviruses and immunoprecipitation performed with the 12CA5 anti-HA antibody (Figure 2a) . Conversely, the use of a polyclonal antiserum directed against Xp53 failed to coprecipitate HA XDM2 with Xp53. We assume this eect is due to a masking of MDM2 binding site on p53 by the polyclonal antibodies. Similar experiments indicated that XDM2 is also able to associate with mouse or human p53 proteins (data not shown). In fact, a cocrystal structure of the N-terminal domain of XDM2 bound to a peptide from the N-terminal transactivation domain of human p53 has recently been determined (Kussie et al., 1996) . Crystals of the complex between human MDM2 and human p53 were obtained, but these were not amenable to crystallographic analysis unlike those with XDM2. Thus, the p53/MDM2 interaction is conserved in Xenopus.
To examine the interaction between XDM2 and the L5 ribosomal protein, a similar assay involving . Lysates were immunoprecipitated with the negative control antibody 419, the anti-HA antibody 12CA5, and polyclonal antibodies against Xp53 (a-Xp53). Immunoprecipitates were washed and separated on an 8% SDS polyacrylamide gel which was dried and exposed to autoradiography . 35 S]methionine as described above. Lysates were immunoprecipitated with 419, the XDM2-speci®c antibody 3G5 and 12CA5 followed by washing and separation by SDS ± PAGE. (c) XDM2 binds speci®cally to RNA. Sf9 insect cells that were either uninfected or infected with baculovirus expression vectors for HA HDM2 or HA XDM2 were immunoprecipitated with 419, 12CA5 or 3G5 as indicated. The beads were washed, resuspended in an RNAbinding buer and incubated with 32 P labeled Round 10 RNA, a pool of RNA molecules that binds speci®cally to the RING ®nger domain of MDM2. The beads were washed and counted in a scintillation counter as previously described HA XDM2 . Upon coexpression of XDM2 and mouse HA L5, a complex is detected by immunoprecipitation with the 3G5 antibody (Figure 2b ). The 12CA5 anti-HA antibody immunoprecipitates HA L5, but fails to coimmunoprecipitate XDM2. The inability of 12CA5 to recognize HA L5 in association with MDM2 has been described previously when human or mouse MDM2 are subjected to a similar experiment and may be caused by masking of the HA epitope tag on L5 when MDM2 is complexed with L5 . Also, when MDM2 or XDM2 is complexed with HA L5, the co-immunoprecipitated protein reproducibly migrates slightly faster than free HA L5 (Figure 2b ). However, we assume this protein to be HA-L5 since no contaminating protein or XDM2 cleavage product could be detected by 3G5 in cells expressing separately HA-L5 or XDM2. The slight dierence in mobilities may represent a post-translational modi®cation of L5 when bound by MDM2. Thus, the L5 binding activity of the central acidic domain of MDM2 is conserved in Xenopus.
Human and mouse MDM2 were recently shown to interact selectively with the homopolyribonucleotide poly(G) and to bind RNA speci®cally through its Cterminal RING ®nger domain . Since the RING ®nger is included in the conserved Region III, we evaluated the ability of XDM2 to associate with Round 10 RNA, a pool of RNA molecules isolated from a SELEX procedure that binds with high anity to the RING ®nger domains of HDM2 and MDM2 . This interaction was proved to be highly sensitive to the RING ®nger structure since a single glycine-to-serine change at position 446 on mouse MDM2 totally abrogates the binding . Sf9 insect cell lysates from cells that were uninfected or infected with baculoviruses for expression of HA HDM2 or HA XDM2 were immunoprecipitated with various antibodies followed by incubation with 32 Plabeled Round 10 RNA, washing and counting in a scintillation counter. The 32 P-labeled RNA was only retained on the beads when immunoprecipitations were performed from lysates containing HA HDM2 and HA XDM2 with the 12CA5 and 3G5 antibodies, but not with the 419 negative control antibody (Figure 2c) . Thus, HA XDM2 binds eciently to Round 10 RNA although the amount of associated RNA was slightly lower for HA XDM2 than for HA HDM2. This observation is probably due to the fact that HA XDM2 is expressed at lower levels than HA HDM2 in the insect cells (data not shown). In short, the biochemical activities of binding to the p53 and L5 proteins and speci®cally to RNA are highly conserved from Xenopus to human, consistent with the high degree of amino acid sequence homology between the MDM2 homologs in the conserved Region III.
Xdm2 expression during oogenesis and early development of Xenopus laevis
Northern blot analysis was performed on total RNA extracted from Xenopus oocytes and embryos. Ten mg of total RNA from each developmental stage was separated on the gel and the blot was probed with the full length 24.1 Xdm2 cDNA. In addition, 2 mg of total RNA was subjected to electrophoresis for stage I/II oocyte in order to ensure a constant amount of polyadenylated RNA in each lane (Sagata et al., 1988) . A unique 1.7 kb RNA was detected after a 4 day exposure, indicating that Xdm2 is only weakly expressed during oogenesis and early development (Figure 3a) . Xdm2 gene expression is almost undetectable at oocyte stage I/II, but increases slightly until the oocyte stage V/VI where it reaches a maximum. Xdm2 RNA becomes barely detectable after the blastula stage, demonstrating that Xdm2 expression is mostly Figure 3 Expression of Xdm2 in Xenopus during early development (a) and in dierentiated tissues (b). The Xenopus oocytes, eggs and embryos were obtained and prepared as previously described (Taylor et al., 1986; Dumont, 1972; Nieuwkoop and Faber, 1956) . Total RNA was isolated from various developmental stages as described (Taylor et al., 1986) . ten mg of total RNA was used for each developmental stage or tissue except for the stage I/II oocyte were 2 mg have been analysed to ensure a constant amount of polyadenylated RNA in each lane. RNA was subjected to Northern blot analysis with the complete Xdm2 24.1 cDNA being used as a probe. Hybridization against the 18S rRNA was used as a control. I/II, III/IV and VI refer to oocyte stages I to VI; MBT refers to the midblastula stage. A unique 1.7 kb RNA could be detected from the oocyte stage I/II to the blastula stage. Xdm2 expression could not be detected in any of the dierentiated tissues analysed.
restricted to oogenesis and early development in Xenopus laevis. However, this observation does not exclude the possibility that Xdm2 may be expressed during subsequent stages of development and differentiation. A Xdm2 transcript could also be detected in dividing A6 Xenopus cells at a level comparable to that of oocyte stage VI (data not shown). We could not demonstrate any expression in the heart, eyes, skin, brain, oviduct and testis even after a 10 day exposure (Figure 3b) . Similarly, Xdm2 transcripts were undetectable in spleen, pancreas, liver, stomach, intestine, lung, kidney and muscle (data not shown).
Discussion
A growing set of observations has raised the hypothesis that the MDM2 oncoprotein may perform other functions in addition to its known activity as a regulator of p53. First, MDM2 contains several conserved regions in addition to Region I which is sucient for the binding and regulation of p53. Second, MDM2 interacts with the ribosomal L5 protein and its associated 5S rRNA, this complex being mediated through the central acidic domain of MDM2. Third, it was recently shown that Mdm2 is expressed in normal non-dividing human skin keratinocytes in the absence of detectable p53, thus arguing against a p53-dependent function of MDM2 in these cells (Augias et al., 1996 in press) . If true, one may expect that the domains important for MDM2 protein function are conserved through evolution. Previous results suggested that Mdm2 homologs may exist in chicken, ®sh, Xenopus (Fakharzadeh et al., 1991; unpublished data) and possibly in insect cells (Bae et al., 1995) . We report here the cloning and characterization of Mdm2 homolog(s) in Xenopus laevis. Sequence analysis revealed that three conserved regions, referred to as Regions I to III, are highly conserved from Xenopus to human. Region I comprises the N-terminal domain required for interaction with the p53 and E2F/DP1 proteins; Region II partly covers the central acidic region responsible for interaction with the ribosomal L5 protein and contains a C4 zinc ®nger which shares signi®cant homologies with several RNA binding proteins zinc ®nger domains; and Region III contains the RING ®nger domain. Amino acid homologies within the Region I (61/89 amino acids are identical) and the interactions reported here strongly argue for a conservation of p53 and possibly E2F1/DP1 binding ability of MDM2 during evolution. This predicition was further supported by the fact that 3G5, a monoclonal antibody unable to detect a preformed p53/MDM2 complex, was the only antibody found that recognized XDM2. On Xenopus p53, this interaction is likely to be mediated through the QETFEDLWSL motif which is highly homologous to the QETFSD/GLWKL consensus binding site for MDM2 in mouse and human p53 (Picksley et al., 1994) . Moreover, amino acids on p53 (Leu 14, Phe 19, Leu 22 and Trp 23) that are required for binding to MDM2 are also conserved on Xenopus p53 (Lin et al., 1994) . Identifying conserved amino acids within Region I of MDM2 will help de®ne the sites of interaction between p53 and MDM2 and possibly any structural motifs that may be involved in the p53/MDM2 complex formation. Whether XDM2 also regulates the transcriptional activity and DNA-binding ability of Xp53 has yet to be demonstrated.
Sequence analysis de®ned the RING ®nger domain as the most conserved region of MDM2. RING ®nger domains have been hypothesized to participate in protein-protein interactions or DNA binding (Freemont, 1993) , but recent results established that the MDM2 RING ®nger interacts speci®cally with RNA in vitro . Based upon the experiments reported here, the RNA-binding activity of MDM2 is also conserved during evolution and is likely to be an important function of MDM2. Interestingly, the Drosophila homolog of the baculovirus IAP inhibitor of apoptosis protein, DIAP1, contains a C-terminal RING ®nger domain which is closely related to that of MDM2 (Hay et al., 1995) . Further experiments suggested that the RING ®nger domain of DIAP1 may negatively regulate its antiapoptotic activity. Whether the MDM2 RING ®nger also acts as a cis-regulator or as a trans-regulator of some unde®ned target(s) involved in apoptosis has yet to be investigated. In this regard, it should be noted that a shorter form of murine MDM2 lacking the Cterminal domain, as shown by epitope mapping, was found in MDM2 overexpressing cell lines and may be due alternative splicing or proteolytic processing of its C-terminus .
Finally, we provide preliminary evidence that Mdm2 expression increases from oocyte stage I/II to reach its maximum in oocyte stage V/VI in unfertilized eggs, and then progressivley decreases to become undetectable at the gastrula stage. Since the p53 protein is stored as a large cytoplasmic pool until fertilization (Tchang et al., 1993) , this data would suggest that Mdm2 expression is not dependent on transcriptional activation by p53 during oogenesis, although it cannot be excluded that a small amount of p53 is localized in the nucleus. Similarly, we could not detect a signi®cant increase in Mdm2 expression after the 12th cell division, a stage where p53 is localized in the nucleus and may be transcriptionally active. Elevated gene expression during oogenesis has already been observed for several genes whose activity is required during the ®rst cell divisions, including the p53 gene (Tchang et al., 1993) . We thus may speculate that XDM2 protein accumulates during oogenesis and is required to modulate p53 activity during the ®rst mitosis.
Xenopus p53 retained several biochemical activities through evolution such as DNA binding, transcriptional regulation and oligomerization (Ridgway et al., 1994; Wang et al., 1995) and is induced upon u.v irradiation in somatic cells (Cox et al., 1994) . Moreover, microinjection of Xenopus p53 with subsequent overexpression in two-or four-cell stage embryos leads to lethal eects until the gastrula stage or during gastrulation (Hoever et al., 1994) . As the pre-blastula stage is characterized by a loss of the G 1 and G 2 phases and the absence of signi®cant transcription, a role for p53 in transcriptional regulation is unlikely during this period. It is thus tempting to speculate that p53 acts as a regulator of DNA replication in the absence of any transcriptional activity during this period (Cox et al., 1995) . It will thus be important to evaluate the temporal activation of Xp53 and possible regulation by XDM2 during early embryogenesis. Overexpression of XDM2 in Xenopus eggs or embryos should provide new insights concerning the p53-dependent and possibly independent eects of MDM2 during early developmental stages.
